சுகாதாரம் அலகு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from சுகாதாரம் அலகு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In சுகாதாரம் அலகு Today - Breaking & Trending Today
Studies evaluate the impact of mobility restrictions during lockdown on air quality in urban areas Two studies led by María Morales Suárez Varela, group leader of the CIBERESP at the University of Valencia and professor of the Department of Preventive Medicine and Public Health at the academic institution, have evaluated the impact of mobility restrictions on air quality and polluting emissions, in Valencia and in three Italian cities. The lockdown measures improved air quality in urban areas, but not as much as expected given the alleged contribution of traffic to ambient air pollution , explains the researcher. The restrictive mobility measures to limit the spread of COVID-19 provided a unique opportunity to improve our understanding of the impact of mobility on air pollution in urban areas. ....
Trial to assess antimicrobial nasal spray in treating mild COVID-19 4 The study will assess whether APR-AOS2020 can reduce the viral load of recently infected COVID-19 patients with mild symptoms. Investigators have initiated a study to evaluate the efficacy of APR-AOS2020, a novel nasal spray, in the treatment of COVID-19 patients showing mild symptoms. The study, co-ordinated by lead investigator Professor Giancarlo Icardi, will enrol 57 COVID-19 patients at the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy. The trial will asses the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. According to APR Applied Pharma Research, who developed APR- AOS2020, when the results are available, they could be the staring point for using the therapeutic in the prevention of more severe symptoms, as well as reducing the risk of infection and spread of virus. ....
Share this article Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Results, when available, could represent the startin ....
Share this article Share this article BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Results, when available, could represent the starting point for the use of the product in th ....
12 maggio 2021 16:52 Fonte: Adnkronos #salute-e-benessere Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Resul ....